METABOLIC DISORDER side effect
What is METABOLIC DISORDER ?Drugs associated with METABOLIC DISORDER
AMIODARONE AVANDAMET AVASTIN BACTROBAN CETUXIMAB CITALOPRAM COUMADIN CYTARABINE FORTEO GEMZAR LANTUS NOVORAPID NOVOSEVEN OLANZAPINE OLMESARTAN PARACETAMOL REMICADE RISPERDAL RITALIN SEROQUEL SEVOFLURANE SYNAGIS THEOPHYLLINE VALPROIC VIVITROL XELODA ZYPREXAMETABOLIC DISORDER : Sevoflurane Side Effects Report #5642003-5
Consumer or non-health professional from TURKEY reported SEVOFLURANE problem on Feb 19, 2008. Female patient, child 11 years of age, weighting 66.14 lb, was diagnosed with maintenance of anaesthesia and was treated with SEVOFLURANE. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, renal impairment, . SEVOFLURANE dosage: unknown. During the same period patient was treated with CYCLOSPORINE, AMIKACIN SULPHATE, AMIKACIN SULPHATE, CEFTRIAXONE, SPIRONOLACTONE. Patient recovered.
METABOLIC DISORDER : Sevoflurane Side Effects Report #5645724-3
SEVOFLURANE problem was reported by a Consumer or non-health professional from TURKEY on Feb 27, 2008. Female patient, child 11 years of age, weighting 66.14 lb, was diagnosed with maintenance of anaesthesia and was treated with SEVOFLURANE. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, renal impairment, . SEVOFLURANE dosage: unknown. During the same period patient was treated with CYCLOSPORINE, AMIKACIN SULPHATE, AMIKACIN SULPHATE, CEFTRIAXONE, SPIRONOLACTONE. Patient recovered.
METABOLIC DISORDER : Cetuximab Side Effects Report #5598869-0
Health Professional from UNITED STATES reported CETUXIMAB problem on Jan 15, 2008. Male patient, 85 years of age, weighting 156.5 lb, was diagnosed with colorectal cancer metastatic, mineral supplementation, gastrooesophageal reflux disease, hypertension, medical diet, lipids increased and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, sepsis, . CETUXIMAB dosage: unknown. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN, CALCIUM GLUCONATE, NEXIUM, VASOTEC, ZOCOR. Patient was hospitalized. Patient died on 11/05/2007.
METABOLIC DISORDER : Coumadin Side Effects Report #5537073-9
COUMADIN problem was reported by a Health Professional from UNITED STATES on Dec 06, 2007. Male patient, 39 years of age, was diagnosed with bacterial infection and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, prothrombin time prolonged, . COUMADIN dosage: unknown. During the same period patient was treated with BACTROBAN, VALPROATE, FRUSEMIDE, LEXAPRO, DONNATAL, VANCOMYCIN, METRONIDAZOLE, LORAZEPAM. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Risperdal Side Effects Report #5571532-8
Physician from BELGIUM reported RISPERDAL problem on Dec 18, 2007. Male patient, 17 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, . RISPERDAL dosage: unknown. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5540645-9
ZYPREXA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2007. Female patient, 41 years of age, weighting 250.0 lb, was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, pancreatitis, type 2 diabetes mellitus, weight increased, . ZYPREXA dosage: unknown. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5542403-8
Physician from UNITED STATES reported ZYPREXA problem on June 21, 2007. Female patient, 13 years of age, was diagnosed with schizophrenia and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, type 2 diabetes mellitus, . ZYPREXA dosage: 20 MG, DAILY (1/D), ORAL. During the same period patient was treated with CLONIDINE. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Valproic Side Effects Report #5446863-2
VALPROIC ACID problem was reported by a Consumer or non-health professional from FRANCE on Aug 30, 2007. Female patient, 22 years of age, was diagnosed with partial seizures and was treated with VALPROIC ACID. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, visual field defect, . VALPROIC ACID dosage: 1500 MG DAILY. During the same period patient was treated with VALPROIC ACID. Patient was hospitalized and became disabled. Patient recovered.
METABOLIC DISORDER : Seroquel Side Effects Report #5455415-X
Health Professional from UNITED STATES reported SEROQUEL problem on Mar 30, 2007. Female patient, weighting 185.4 lb, was diagnosed with sleep disorder and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, obesity, tardive dyskinesia, . SEROQUEL dosage: unknown. During the same period patient was treated with NAVANE, RISPERDAL. Patient recovered.
METABOLIC DISORDER : Valproic Side Effects Report #5465653-8
VALPROIC ACID problem was reported by a Physician from AUSTRIA on Sept 19, 2007. Female patient, 22 years of age, was diagnosed with convulsion and was treated with VALPROIC ACID. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, visual field defect, . VALPROIC ACID dosage: unknown. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Lantus Side Effects Report #5675083-1
Consumer or non-health professional from UNITED STATES reported LANTUS problem on Mar 17, 2008. Male patient, 63 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, visual disturbance, . LANTUS dosage: unknown. Patient recovered.
METABOLIC DISORDER : Synagis Side Effects Report #5535081-5
SYNAGIS problem was reported by a Physician from CANADA on Nov 19, 2007. Female patient, weighting 8.17 lb, was diagnosed with antiviral prophylaxis and was treated with SYNAGIS. After drug was administered, patient experienced the following problems/side effects: convulsion, metabolic disorder, . SYNAGIS dosage: 56 MG, INTRAMUSCULAR. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Cytarabine Side Effects Report #5563289-1
Consumer or non-health professional from NETHERLANDS reported CYTARABINE problem on Nov 12, 2007. Male patient, 65 years of age, weighting 209.4 lb, was diagnosed with acute myeloid leukaemia, epilepsy and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: encephalopathy, metabolic disorder, . CYTARABINE dosage: 200 MG/M2,. During the same period patient was treated with KEPPRA, AVASTIN, FRISIUM, FUNGIZONE, METOPROLOL SUCCINAAT, KONAKION, HALDOL, FLUCONAZOLE. Patient recovered.
METABOLIC DISORDER : Novoseven Side Effects Report #5568075-4
NOVOSEVEN problem was reported by a Physician from ARGENTINA on Dec 17, 2007. Female patient was diagnosed with post procedural haemorrhage and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: ischaemic stroke, metabolic disorder, renal disorder, . NOVOSEVEN dosage: unknown. During the same period patient was treated with DOPAMINE. Patient was hospitalized. Patient died on 09/29/2007.
METABOLIC DISORDER : Theophylline Side Effects Report #5578740-0
Health Professional from CZECH REPUBLIC reported THEOPHYLLINE problem on Dec 12, 2007. Female patient was treated with THEOPHYLLINE. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, suicide attempt, . THEOPHYLLINE dosage: unknown. Patient recovered.
METABOLIC DISORDER : Novorapid Side Effects Report #5509818-5
NOVORAPID FLEXPEN problem was reported by a Consumer or non-health professional from ITALY on Oct 29, 2007. Female patient was diagnosed with type 1 diabetes mellitus and was treated with NOVORAPID FLEXPEN. After drug was administered, patient experienced the following problems/side effects: medical device complication, metabolic disorder, . NOVORAPID FLEXPEN dosage: unknown. During the same period patient was treated with AXAGON, SYMBICORT, FLIXONASE. Patient recovered.
METABOLIC DISORDER : Forteo Side Effects Report #5518074-3
Physician from UNITED STATES reported FORTEO problem on Nov 01, 2007. Female patient, weighting 107.0 lb, was diagnosed with osteoporosis, hypertension, peripheral vascular disorder, hyperlipidaemia, hypothyroidism and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: arthralgia, metabolic disorder, paralysis, . FORTEO dosage: unknown. During the same period patient was treated with HYZAAR, PLAVIX, LOVASTATIN, NORVASC, SYNTHROID. Patient recovered.
METABOLIC DISORDER : Remicade Side Effects Report #5523595-3
REMICADE problem was reported by a Physician from NORWAY on Nov 15, 2007. Female patient was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: epilepsy, metabolic disorder, . REMICADE dosage: unknown. Patient recovered.
METABOLIC DISORDER : Ritalin Side Effects Report #5524468-2
Consumer or non-health professional from UNITED KINGDOM reported RITALIN problem on Nov 12, 2007. Male patient was treated with RITALIN. After drug was administered, patient experienced the following problems/side effects: lactose intolerance, metabolic disorder, underweight, . RITALIN dosage: 45MG DAILY. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5540824-0
ZYPREXA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2007. Female patient, 41 years of age, weighting 263.0 lb, was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, metabolic disorder, overdose, pancreatitis, weight decreased, . ZYPREXA dosage: 10 MG,; 80 MG,. During the same period patient was treated with RISPERIDONE, GEODON, WELLBUTRIN, PROZAC, REMERON, PREDNISONE. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5542480-4
Consumer or non-health professional from UNITED STATES reported ZYPREXA problem on June 04, 2007. Male patient, 41 years of age, weighting 209.9 lb, was diagnosed with schizophrenia and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, metabolic disorder, overdose, pancreatitis, . ZYPREXA dosage: 15 MG, DAILY (1/D). During the same period patient was treated with OLANZAPINE, QUETIAPINE, PROPRANOLOL, TRIAMCINOLONE. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5551620-2
ZYPREXA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 06, 2007. Female patient, 42 years of age, weighting 205.9 lb, was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, metabolic disorder, type 2 diabetes mellitus, . ZYPREXA dosage: 5 MG, 7.5 MG, 15 MG, 20 MG. During the same period patient was treated with RISPERDAL, HALOPERIDOL DECANOATE, DEPAKOTE, ALREX. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5551972-3
Consumer or non-health professional from UNITED STATES reported ZYPREXA problem on June 18, 2007. Female patient, 30 years of age, weighting 235.9 lb, was diagnosed with schizophrenia and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, metabolic disorder, obesity, polyuria, type 2 diabetes mellitus, . ZYPREXA dosage: 20 MG; 20 MG. During the same period patient was treated with ABILIFY, LEXAPRO. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Avastin Side Effects Report #5487186-5
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Oct 01, 2007. Female patient was diagnosed with colorectal cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, metabolic disorder, nausea, vomiting, . AVASTIN dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Olanzapine Side Effects Report #5488187-3
Consumer or non-health professional from UNITED STATES reported OLANZAPINE problem on Oct 08, 2007. Female patient, weighting 364.9 lb, was diagnosed with bipolar disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: cholecystectomy, metabolic disorder, type 2 diabetes mellitus, weight increased, . OLANZAPINE dosage: 10 MG, UNK. During the same period patient was treated with ARIPIPRAZOLE, RISPERIDONE, LITHIUM, PAROXETINE. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Avandamet Side Effects Report #5493205-2
AVANDAMET problem was reported by a Physician from NETHERLANDS on Oct 19, 2007. Male patient, 58 years of age, weighting 167.6 lb, was treated with AVANDAMET. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, metabolic disorder, . AVANDAMET dosage: unknown. During the same period patient was treated with METFORMIN, DIAMICRON. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Forteo Side Effects Report #5468223-0
Physician from UNITED STATES reported FORTEO problem on Sept 17, 2007. Female patient, 76 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: arthralgia, metabolic disorder, paralysis, . FORTEO dosage: unknown. Patient recovered.
METABOLIC DISORDER : Gemzar Side Effects Report #5409674-X
GEMZAR problem was reported by a Physician from FRANCE on Aug 06, 2007. Male patient, 73 years of age, was diagnosed with bladder cancer, arthralgia and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: dehydration, metabolic disorder, renal failure acute, . GEMZAR dosage: unknown. During the same period patient was treated with KAYEXALATE, PARACETAMOL, ANTIINFLAMMATORY, ATARAX, FORLAX, CISPLATIN, ANGIOTENSIN II ANTAGONISTS. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Avandamet Side Effects Report #5381982-0
Consumer or non-health professional from NETHERLANDS reported AVANDAMET problem on July 04, 2007. Male patient, 58 years of age, weighting 167.6 lb, was treated with AVANDAMET. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, metabolic disorder, . AVANDAMET dosage: unknown. During the same period patient was treated with METFORMINE, DIAMICRON. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Amiodarone Side Effects Report #5385483-5
AMIODARONE problem was reported by a Physician from UNITED STATES on June 26, 2007. Male patient, 76 years of age, was diagnosed with atrial fibrillation and was treated with AMIODARONE. After drug was administered, patient experienced the following problems/side effects: ileus, metabolic disorder, primary hypothyroidism, small intestinal obstruction, . AMIODARONE dosage: 200MG/DAY. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Citalopram Side Effects Report #5391682-9
Health Professional from DENMARK reported CITALOPRAM HYDROBROMIDE problem on July 05, 2007. Female patient, 18 years of age, was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: dizziness, metabolic disorder, nausea, pulmonary haemorrhage, vision blurred, vomiting, . CITALOPRAM HYDROBROMIDE dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE. Patient recovered.
METABOLIC DISORDER : Avandamet Side Effects Report #5381982-0
AVANDAMET problem was reported by a Consumer or non-health professional from NETHERLANDS on July 04, 2007. Male patient, 58 years of age, weighting 167.6 lb, was treated with AVANDAMET. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, metabolic disorder, . AVANDAMET dosage: unknown. During the same period patient was treated with METFORMINE, DIAMICRON. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Amiodarone Side Effects Report #5385483-5
Physician from UNITED STATES reported AMIODARONE problem on June 26, 2007. Male patient, 76 years of age, was diagnosed with atrial fibrillation and was treated with AMIODARONE. After drug was administered, patient experienced the following problems/side effects: ileus, metabolic disorder, primary hypothyroidism, small intestinal obstruction, . AMIODARONE dosage: 200MG/DAY. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Citalopram Side Effects Report #5391682-9
CITALOPRAM HYDROBROMIDE problem was reported by a Health Professional from DENMARK on July 05, 2007. Female patient, 18 years of age, was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: dizziness, metabolic disorder, nausea, pulmonary haemorrhage, vision blurred, vomiting, . CITALOPRAM HYDROBROMIDE dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE. Patient recovered.
METABOLIC DISORDER : Xeloda Side Effects Report #5653374-8
Physician from NETHERLANDS reported XELODA problem on Feb 20, 2008. Female patient, 77 years of age, weighting 138.9 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, metabolic disorder, stomatitis, . XELODA dosage: DOSE REPORTED AS 2X1000MG/M2. During the same period patient was treated with OXALIPLATIN. Patient died on 01/28/2008.
METABOLIC DISORDER : Olmesartan Side Effects Report #5622214-5
OLMESARTAN MEDOXOMIL problem was reported by a Consumer or non-health professional from SPAIN on Jan 25, 2008. Male patient, 77 years of age, was diagnosed with hypertension and was treated with OLMESARTAN MEDOXOMIL. After drug was administered, patient experienced the following problems/side effects: acidosis, electrolyte imbalance, metabolic disorder, renal failure acute, . OLMESARTAN MEDOXOMIL dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ANAGASTRA, ISCOVER, SPIRIVA. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Vivitrol Side Effects Report #5599996-4
Physician from UNITED STATES reported VIVITROL problem on Jan 02, 2008. Female patient, weighting 129.0 lb, was diagnosed with alcohol use and was treated with VIVITROL. After drug was administered, patient experienced the following problems/side effects: injection site erythema, injection site mass, metabolic disorder, . VIVITROL dosage: unknown. During the same period patient was treated with SEROQUEL, TRILEPTAL, LEXAPRO, CAMPRAL, FLONASE, VITAMIN CAP. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5567871-7
ZYPREXA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 10, 2007. Male patient, weighting 287.0 lb, was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: glucose tolerance impaired, hypertension, metabolic disorder, obesity, . ZYPREXA dosage: unknown. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Bactroban Side Effects Report #5522183-2
Health Professional from UNITED STATES reported BACTROBAN problem on Nov 15, 2007. Male patient, 39 years of age, was treated with BACTROBAN. After drug was administered, patient experienced the following problems/side effects: blood magnesium increased, blood potassium increased, metabolic disorder, mineral metabolism disorder, prothrombin time prolonged, . BACTROBAN dosage: unknown. During the same period patient was treated with COUMADIN, DEPAKOTE, LASIX, LEXAPRO, DONNATAL, VANCOMYCIN, VALTREX, FLAGYL. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5542315-X
ZYPREXA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 19, 2007. Female patient, 83 years of age, weighting 100.1 lb, was diagnosed with bipolar disorder and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, hypertension, metabolic disorder, pancreatitis, . ZYPREXA dosage: 5 MG. During the same period patient was treated with QUETIAPINE, CITALOPRAM HYDROBROMIDE, MIRTAZAPINE. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5551537-3
Consumer or non-health professional from UNITED STATES reported ZYPREXA problem on July 24, 2007. Male patient, 40 years of age, weighting 192.9 lb, was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: glucose urine present, hypoglycaemia, metabolic disorder, overdose, type 2 diabetes mellitus, . ZYPREXA dosage: 30 MG. During the same period patient was treated with ABILIFY, RISPERDAL, GEODON, THORAZINE, HALDOL, PROZAC, MICROZIDE. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5551608-1
ZYPREXA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 10, 2007. Female patient, child 8 years of age, weighting 84.88 lb, was diagnosed with bipolar i disorder and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: acetonaemia, diabetes mellitus, metabolic disorder, nocturia, . ZYPREXA dosage: 2.5 MG,. During the same period patient was treated with ZOLOFT, SEROQUEL. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5551677-9
Consumer or non-health professional from UNITED STATES reported ZYPREXA problem on Apr 02, 2007. Male patient, 37 years of age, weighting 220.0 lb, was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, hypertension, metabolic disorder, weight increased, . ZYPREXA dosage: 5 MG, 2/D ORAL. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5551724-4
ZYPREXA problem was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2007. Female patient, 59 years of age, weighting 158.1 lb, was diagnosed with depression and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: convulsion, diabetes mellitus, metabolic disorder, . ZYPREXA dosage: 2.5 MG. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5552002-X
Consumer or non-health professional from UNITED STATES reported ZYPREXA problem on May 10, 2007. Male patient, 45 years of age, weighting 69.00 lb, was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: diabetic ketoacidosis, hypertension, metabolic disorder, type 2 diabetes mellitus, vision blurred, . ZYPREXA dosage: 10 MG. During the same period patient was treated with RISPERIDONE, DIVALPROEX, BUPROPION. Patient recovered.
METABOLIC DISORDER : Risperdal Side Effects Report #5479252-5
RISPERDAL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2007. Male patient, weighting 240.0 lb, was diagnosed with obsessive-compulsive disorder, tourette's disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: diabetic ketoacidosis, hypertriglyceridaemia, metabolic disorder, pancreatitis acute, weight increased, . RISPERDAL dosage: unknown. During the same period patient was treated with SEROQUEL, TRILEPTAL, GUANFACINE HYDROCHLORIDE, LUVOX, RITALIN, MINOCYCLINE. Patient was hospitalized. Patient died on 07/12/2005.
METABOLIC DISORDER : Risperdal Side Effects Report #5463253-7
Health Professional from UNITED STATES reported RISPERDAL problem on Sept 11, 2007. Male patient, weighting 240.0 lb, was diagnosed with obsessive-compulsive disorder, tourette's disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: diabetic ketoacidosis, hypertriglyceridaemia, metabolic disorder, pancreatitis acute, weight increased, . RISPERDAL dosage: unknown. During the same period patient was treated with SEROQUEL, TRILEPTAL, GUANFACINE HYDROCHLORIDE, LUVOX, RITALIN, MINOCYCLINE. Patient was hospitalized. Patient died on 07/12/2005.
METABOLIC DISORDER : Zyprexa Side Effects Report #5467846-2
ZYPREXA problem was reported by a Physician from GERMANY on Sept 19, 2007. Male patient was diagnosed with schizophrenia and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, lipids increased, metabolic disorder, . ZYPREXA dosage: unknown. During the same period patient was treated with RISPERDAL. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5356463-0
Consumer or non-health professional from UNITED STATES reported ZYPREXA problem on Dec 06, 2006. Male patient, 50 years of age, weighting 200.0 lb, was diagnosed with depression and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: convulsion, diabetes mellitus, metabolic disorder, vision blurred, . ZYPREXA dosage: 10 MG. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Paracetamol Side Effects Report #5391258-3
PARACETAMOL problem was reported by a Physician from UNITED STATES on July 03, 2007. Male patient, weighting 30.20 lb, was diagnosed with analgesia and was treated with PARACETAMOL. After drug was administered, patient experienced the following problems/side effects: apnoea, cerebral infarction, metabolic disorder, miosis, unresponsive to stimuli, . PARACETAMOL dosage: 1.75 MG/KG/DOSE; 2 SINGLE DOSES DURING 5 HRS; 12-24 MG/DOSE, 4/TIMES DAY; 1.75 MG/KG, ONCE/SINGLE. During the same period patient was treated with FENTANYL, ONDANSETRON, HYDROCORTISONE, MORPHINE, SEVOFLURANE. Patient was hospitalized. Patient recovered.
METABOLIC DISORDER : Zyprexa Side Effects Report #5356463-0
Consumer or non-health professional from UNITED STATES reported ZYPREXA problem on Dec 06, 2006. Male patient, 50 years of age, weighting 200.0 lb, was diagnosed with depression and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: convulsion, diabetes mellitus, metabolic disorder, vision blurred, . ZYPREXA dosage: 10 MG. Patient was hospitalized. Patient recovered.